NEWS OUT ! LAGUNA HILLS, CA--(Marketwired - Mar 2
Post# of 1230
NEWS OUT !
LAGUNA HILLS, CA--(Marketwired - Mar 26, 2014) - Itonis, Inc. (PINKSHEETS: ITNS) today issued the following update to its shareholders:
The Company recently announced that it had entered into a letter of intent to license a proprietary mobile app from MyECheck, Inc. to facilitate point of purchase transactions for medical marijuana, gambling and general retail sales. We are on track to finalize the licensing details soon. Through our pharmaceutical relationships, we noticed an unmet demand regarding medical marijuana and the point of sales from medical suppliers. We believe that there is a significant revenue opportunity in addressing this demand with MyECheck's proprietary payment app and connecting it to the medical marijuana sector.
We also announced that Dr. Charles Hensley approved the Emesyl(TM) nausea remedy for manufacturing. Dr. Hensley tested the different samples sent by the manufacturer and has selected the more superior sample to be used for production.
We are proud and excited about the future in both of these ventures and we will continue to work hard delivering quality and profitable products to our customers and shareholders.
We plan to update our shareholders soon on the finalized licensing with MyECheck, Inc. and the next steps on manufacturing Emesyl(TM).
Thank you for your continuing support of the Company.
Mark Cheung
CEO / President
About Itonis, Inc.
(0)
(0)